tirzepatide to semaglutide vs. Semaglutide: What's the Difference? Semaglutide vs Tirzepatide - Pro

We view MariTides potential for less bi-monthly or quarterly frequent maintenance dosing as a compelling area of further differentiation. Additional data remained elusive during Tuesdays presentation, and the pharma did not provide a specific timeline for when it expects to release these findings

The FDA has approved the following GLP-1 medications for heart health

The consequences of these modifications are that IGF-1 LR3 retains the pharmacological activity of IGF-1 as an agonist of the IGF-1 receptor, has very low affinity for the insulin-like growth factor-binding proteins (IGFBPs), and has improved metabolic stability resulting in approximately three times greater potency than IGF-1, with a significantly longer half-life of about 2030 hours relative to IGF-1s half-life of about 1215 hours

Retatrutide's approximately 6-day half-life is what makes once-weekly dosing appropriate